Biliary stent migration represents a significant clinical challenge, occurring when stents inserted to relieve biliary obstructions dislodge from their intended positions. This phenomenon can lead to ...

BOSTON – Although approved by the U.S. Food and Drug Administration as a palliative treatment for cancer patients who have developed bile-duct obstructions, biliary stents are sometimes used ...

Natick, MA – Boston Scientific Corporation’s WallFlex® Biliary RX Fully Covered Stent has received Health Canada approval for the treatment of benign biliary strictures, which supplements its current ...

Boston Scientific published a multinational study in the journal Gastroenterology that evaluates the removability and long-term stricture resolution of benign biliary strictures in relation to the use ...

NATICK, Mass., Boston Scientific Corporation has completed enrollment in a clinical trial to evaluate its WallFlex® Biliary RX Fully Covered Stent for the treatment of benign bile duct strictures ...

Time-period from presentation to anticipated surgery: if a patient may undergo pancreaticoduodenectomy within a few days of presentation and is a candidate for surgery, no instrumentation may be ...

Etoposide and Cisplatin/Etoposide, Methotrexate, and Actinomycin D (EMA) Chemotherapy for Patients With High-Risk Gestational Trophoblastic Tumors Refractory to EMA/Cyclophosphamide and Vincristine ...

At the 2021 Cholangiocarcinoma Foundation Annual Conference, experts discussed guidelines and real-world data for the management of urgent symptoms in patients with cholangiocarcinoma who have biliary ...

Please provide your email address to receive an email when new articles are posted on . “The appropriate diagnosis and management of biliary strictures has important implications in endoscopic, ...